Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003854 · ClinicalTrials.gov registry record · Phase 3
Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
A Phase 3 study, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- Phase 3
- Development phase
- 4,590
- Enrollment target
NCT00003854: Completed Phase 3 study, sponsored by Alliance for Clinical Trials in Oncology.
NCT00003854 is a Phase 3 study that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 4,590 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (495% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003854, a Phase 3 study, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 4,590 participants
- Enrollment target
Study Summary
RATIONALE: Biopsy of sentinel lymph nodes and bone marrow may improve the ability to detect and determine the extent of cancer. PURPOSE: Phase III prognostic study of sentinel lymph node metastases and bone marrow metastases in women who have stage I or stage IIA breast cancer.
Interventions
- OTHER immunohistochemistry staining method
- PROCEDURE therapeutic conventional surgery
- RADIATION whole breast irradiation
- PROCEDURE lymphangiography
- PROCEDURE sentinel lymph node biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,590 participants |
| Start Date | 1999-04 |
| Est. Completion | 2011-07 |
| Phase | Phase 3 |
What the finished NCT00003854 record still lists
NCT00003854 is an interventional study that assigns participants to a tested intervention. Its 4,590 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (495% higher).
The record links to 0 conditions, and to 5 interventions - of which immunohistochemistry staining method is the first listed.
NCT00003854 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003854 about?
NCT00003854 is a clinical study titled "Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer". RATIONALE: Biopsy of sentinel lymph nodes and bone marrow may improve the ability to detect and determine the extent of cancer. PURPOSE: Phase III prognostic study of sentinel lymph node metastases and bone marrow metastases in women who have stage I or stage IIA breast cancer.
What is the current status of trial NCT00003854?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 4,590 participants. The study started on 1999-04. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00003854?
The interventions under investigation include: immunohistochemistry staining method (OTHER), therapeutic conventional surgery (PROCEDURE), whole breast irradiation (RADIATION), lymphangiography (PROCEDURE), sentinel lymph node biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00003854?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00003854's enrollment target sits among peer trials
4,590 54th of 2000 higher than 1,947 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05768217 · 4,600 participants · NA
Community Resiliency Collective Efficacy Intervention
- NCT06535139 · 4,630 participants · NA
ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
- NCT06702878 · 4,514 participants · Phase 3
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections
- NCT06533111 · 4,500 participants · NA
Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia